Get the content you want anytime you want.

Gold Nanoparticle-Targeted Laser Therapy for Enhancement of Antibiotic Efficacy against MRSA Biofilms


I am an employee of the US government. This work was prepared as part of my official duties. Title 17 U.S.C. §105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17 U.S.C. §101 defines a US government work as a work prepared by a military service member or employee of the US government as part of that person’s official duties. The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the US government. This work was funded by Naval Medical Research Center's Advanced Medical Development Program using work unit number G1025.   
1. Millenbaugh NJ, Baskin JB, DeSilva MN, Elliott WR, Glickman RD. Photothermal killing of Staphylococcus aureus using antibodytargeted gold nanoparticles. Int J Nanomedicine. 2015;10:1953-1960.
2. Zhao J, Wallace M, Melancon MP. Cancer theranostics with gold nanoshells. Nanomedicine (Lond). 2014;9(13):2041-2057.
3. Schomaker M, Heinemann D, Kalies S, et al. Characterization of nanoparticle mediated laser transfection by femtosecond laser pulses for applications in molecular medicine. J Nanobiotechnology. 2015;13:10.
4. Blackledge MS, Worthington RJ, Melander C. Biologically inspired strategies for combating bacterial biofilms. Curr Opin Pharmacol. 2013;13(5):699-706.
5. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2013. CDC website. drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Published April 23, 2013. Accessed September 8, 2016.
6. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12.
7. Khoury AE, Lam K, Ellis B, Costerton JW. Prevention and control of bacterial infections associated with medical devices. ASAIO J. 1992;38(3):M174-178.
8. Worthington RJ, Richards JJ, Melander C. Small molecule control of bacterial biofilms. Org Biomol Chem. 2012;10(37):7457-7474.
9. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-193.
10. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: Properties, regulation and roles in human disease. Virulence. 2011;2(5):445-459.
11. Zharov VP, Mercer KE, Galitovskaya EN, Smeltzer MS. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J. 2006;90(2):619-627.
12. Cobley CM, Au L, Chen J, Xia Y. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Deliv. 2010;7(5):577-587.
13. Coggan KA. Nitric oxide is bactericidal to the ESKAPE pathogens: Time for a radical approach. Novan, Inc. website. www. oxide.pdf. Published 2013. Accessed September 13, 2016.
14. Scott RD. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. www. Published March 2009. Accessed September 12, 2016.
15. Meeker DG, Jenkins SV, Miller EK, et al. Synergistic photothermal and antibiotic killing of biofilm-associated Staphylococcus aureus using targeted antibiotic-loaded gold nanoconstructs. ACS Infect Dis 2016;2:241−250.    
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.

Big advances in treatment can